pocketful logo light
pocketful logo light
Aarti Drugs Ltd logo

Aarti Drugs Ltd

NSE: AARTIDRUGS BSE: 524348

₹428.50

(1.95%)

Tue, 22 Sept 2026, 01:41 pm

mtf coin illustrationMTF 5x

Aarti Drugs Share Price Live Chart

1 Day

(1.95%)

No Result Found

Summary

  • Market Cap (in Cr)

    3481.49

  • Net Profit (in Cr)

    168.1

  • P/B

    2.27

  • Sector P/E

    33.76

  • P/E

    18.45

  • EV/EBITDA

    12.10

  • Debt/Equity (Industry)

    0.17

  • Interest Cover (Industry)

    18.17

  • ROCE (Industry)

    20.59

  • RONW (Industry)

    17.62

  • ROE

    12.68

  • ROCE

    13.07

  • Debt/Equity

    0.44

  • EPS (TTM)

    21.36

  • Dividend Yield

    0

  • Book Value

    169.70

  • Interest Cover

    6.42

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters55.0355.0354.7255.2255.48
FII1.582.152.692.262.25
DII10.2210.129.909.949.70
Public33.1832.7032.6932.5832.57
Government00000

Read More

Technical Analysis

RSI

51.58

MACD

3.82

50 DMA

419.73

200 DMA

387.37

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic521.58472.43442.07423.28392.92374.13324.98
Fibonacci472.43453.66442.06423.28404.51392.91374.13
Camarilla425.22420.71416.21423.28407.19402.69398.18

Pivots Level: Classic

R3

+98.30

521.58

R2

+49.15

472.43

R1

+18.78

442.07

423.28
423.28
Pivot Point
LTP: 425.75

S1

-30.37

392.92

S2

-49.15

374.13

S3

-98.30

324.98

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    428.09

  • 20-EMA

    425.39

  • 30-EMA

    422.56

  • 50-EMA

    416.51

  • 100-EMA

    406.20

  • 200-EMA

    405.79

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
15 May 2026board-meetingsAccounts, Quarterly Results
03 Feb 2026board-meetingsAccounts, Quarterly Results, Interim Dividend
03 Feb 2026dividend₹2.00 Dividend /Share09 Feb 2026
09 Jan 2026dividendInterim Dividend - Rs. - 209 Feb 2026
07 Nov 2025board-meetingsQuarterly Results
01 Sept 2025agm
29 Jan 2025dividend₹1.00 Dividend /Share04 Feb 2025
04 Jan 2025dividendInterim Dividend - Rs. - 104 Feb 2025
02 Sept 2024agm
26 Aug 2024buyback

Read More

Peer Comparison

Aarti Drugs Ltd logo

Aarti Drugs Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Aarti Drugs Ltd About

Aarti Drugs is primarily involved in manufacturing and marketing of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1984

Headquarters

CEO

Chandrakant V. Gogri

Employees

Contact

Website icon

Website

http://www.aartidrugs.com

Email icon

Email

investorrelations@aartidrugs.com

Phone icon

Phone

91-22-24072249

Location icon

Location

Plot No N-198 MIDC Tarapur, Pamtembhi Village Palghar Tal, Thane, Maharashtra, 401506

Read More

Aarti Drugs Ltd Company History

YearHistory
2015
  • Aarti Drugs Ltd will participate at 'Centrum Pharma Day' Investor Conference
  • The Company has allotted the Bonus Shares to its shareholders in the Ratio of 1:1
2020
  • The Company has issued Bonus Shares in the Ratio of 3:1
2023
  • Aarti Drugs Limited won Pharmexcil Outstanding Exports Awards 2021-22
2024
  • The Company Initiating Commercial Production of Dermatology Product at New Facility in Tarapur, Maharashtra
2025
  • Aarti Drugs Limited has informed the Exchange about Commencement of commercial production/operation.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GRAVITON RESEARCH CAPITAL LLPbulkSell803687393.6207 May 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy803477393.107 May 2025
BLEND FUND 2bulkBuy511571484.9728 May 2024
MIRIK RAJENDRA GOGRIbulkSell468378485.528 May 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy480077554.1718 Oct 2023
GRAVITON RESEARCH CAPITAL LLPbulkSell480077554.718 Oct 2023
GRAVITON RESEARCH CAPITAL LLPbulkBuy933060627.8925 Jul 2023
GRAVITON RESEARCH CAPITAL LLPbulkSell933060628.425 Jul 2023
QE SECURITIESbulkBuy497273587.7724 Jul 2023
GRAVITON RESEARCH CAPITAL LLPbulkBuy643754575.8824 Jul 2023

Read More

Aarti Drugs Ltd News

Aarti Drugs Appoints Adhish P. Patil as MD for Five Years

Aarti Drugs appoints Adhish P. Patil as Managing Director for a five-year term beginning October 1, 2026, marking a key leadership development for the company.

31 Jul 2026

companies

Aarti Drugs Q1 Results: Revenue Up, Profit Dips YoY

Aarti Drugs posts Q1 revenue of 7B rupees vs 5.9B YoY; EBITDA margin expands to 13.97%, while consolidated net profit slips to 502M rupees from 539M.

31 Jul 2026

companies

Aarti Drugs Q1 FY27 Earnings Call Set for Aug 3

Aarti Drugs has scheduled its Q1 FY27 earnings conference call for August 3, 2026, at 11:00 AM IST to discuss financial performance for the quarter ended June 30, 2026.

29 Jul 2026

companies

Aarti Drugs Ordered to Shut Amines Plant by GPCB

Gujarat Pollution Control Board has directed Aarti Drugs to shut down its Amines plant, marking a significant regulatory development for the pharmaceutical company.

20 Jul 2026

companies

Aarti Drugs promoter group encumbers shares

Promoter group members Mirik Rajendra Gogri and Renil Rajendra Gogri encumbered 6,41,814 and 5,97,957 shares respectively as on March 31, 2026.

02 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Aarti Drugs Ltd?

    As of 22/09/2026 at 7:11 PM, Aarti Drugs Ltd shares are trading at ₹428.50.

  • 2.What is the market cap. of Aarti Drugs Ltd?

    As of 22/09/2026, the market capitalization of Aarti Drugs Ltd is ₹3,909.55 crore.

  • 3.When was Aarti Drugs Ltd founded?

    Aarti Drugs Ltd was founded in 1984.

  • 4.What are the P/E and P/B ratios of Aarti Drugs Ltd?

    As of 22/09/2026, Aarti Drugs Ltd has a P/E ratio of 20.46 and a P/B ratio of 2.27.

  • 5.How can I buy shares of Aarti Drugs Ltd?

    You can buy shares of Aarti Drugs Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Aarti Drugs Ltd?

    As of March,2026, promoters hold 55.03% in Aarti Drugs Ltd, while FIIs, DIIs and public shareholders hold 1.58%, 10.22% and 33.18%, respectively.

  • 7.Does Aarti Drugs Ltd pay dividends?

    Yes, Aarti Drugs Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹2.00 Dividend /Share per share.

  • 8.What is the dividend yield of Aarti Drugs Ltd?

    As of 22 September, 2026, the dividend yield of Aarti Drugs Ltd stands at 0.47%.

  • 9.What are the latest financial results of Aarti Drugs Ltd?

    For January,2024, Aarti Drugs Ltd reported revenue of ₹2,379.00 crore and a net profit of ₹168.00 crore.

  • 10.What is the Stock symbol of Aarti Drugs Ltd?

    AARTIDRUGS is the stock symbol of Aarti Drugs Ltd.

  • 11.Who is the CEO of Aarti Drugs Ltd?

    The CEO of Aarti Drugs Ltd is Chandrakant V. Gogri.

Open Your Free Demat Account

Enter your phone number